Heme oxygenase 1 and renal ischemia and reperfusion injury: the impact of immunosuppressive drug.

[1]  H. Rabb,et al.  Effects of Combined T‐ and B‐Cell Deficiency on Murine Ischemia Reperfusion Injury , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  H. Drummond,et al.  Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[3]  N. Câmara,et al.  Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. , 2005, Free radical biology & medicine.

[4]  J. Squifflet,et al.  Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  K. Hatakeyama,et al.  Augmentation of Heme Oxygenase-1 Expression in the Graft Immediately After Implantation in Adult Living-Donor Liver Transplantation , 2005, Transplantation.

[6]  F. Di Maggio,et al.  Molecular Mechanisms of Acute Renal Failure following Ischemia/Reperfusion , 2004, The International journal of artificial organs.

[7]  Giuseppe Remuzzi,et al.  Delayed graft function in kidney transplantation , 2004, The Lancet.

[8]  Toru Takahashi,et al.  Protective role of heme oxygenase-1 in renal ischemia. , 2004, Antioxidants & redox signaling.

[9]  R. McTaggart,et al.  Comparison of Outcomes after Delayed Graft Function: Sirolimus-Based Versus Other Calcineurin-Inhibitor Sparing Induction Immunosuppression Regimens , 2004, Transplantation.

[10]  J. Chapman,et al.  Delta Analysis of Posttransplantation Tubulointerstitial Damage , 2004, Transplantation.

[11]  Sudhir V. Shah,et al.  Apoptotic pathways in ischemic acute renal failure. , 2004, Kidney international.

[12]  M. D. de Broe,et al.  T cells as mediators in renal ischemia/reperfusion injury. , 2004, Kidney international.

[13]  H. Rabb,et al.  Immune Responses in Kidney Preservation and Reperfusion Injury , 2004, Journal of Investigative Medicine.

[14]  F. Bach,et al.  Heme oxygenase‐1‐derived carbon monoxide protects hearts from transplant‐associated ischemia reperfusion injury , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  J. Kupiec-Weglinski,et al.  Heme oxygenase system in ischemia and reperfusion injury. , 2003, Annals of transplantation.

[16]  L. Gesualdo,et al.  Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. , 2004, Journal of the American Society of Nephrology : JASN.

[17]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[18]  Jiyeon Kang,et al.  [Health related quality of life among organ transplant recipients]. , 2003, Taehan Kanho Hakhoe chi.

[19]  A. Vandewalle,et al.  To what extent can limiting cold ischaemia/reperfusion injury prevent delayed graft function? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  R. Marquet,et al.  Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine. , 1999, Transplantation.

[21]  K. Nadeau,et al.  Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. , 1997, Transplantation.

[22]  R. Wolfe,et al.  Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.

[23]  G. Schulte,et al.  Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury. , 1996, The Journal of surgical research.

[24]  P. Halloran,et al.  Delayed graft function in renal transplantation: etiology, management and long-term significance. , 1996, The Journal of urology.

[25]  Y. Frishberg,et al.  Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. , 1996, Kidney international.

[26]  A. Monaco,et al.  OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. , 1996, Kidney international.

[27]  T. Strom,et al.  Transplantation biology : cellular and molecular aspects , 1996 .

[28]  S. Tullius,et al.  Both alloantigen-dependent and -independent factors influence chronic allograft rejection. , 1995, Transplantation.

[29]  R. Colvin,et al.  Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Allison,et al.  Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantation , 1993 .

[31]  M. Stegall,et al.  Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function. , 1990, Transplantation.

[32]  M. Moritz,et al.  A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients. , 1989, Transplantation.

[33]  B. Kahan.  Drug therapy: cyclosporine , 1989 .

[34]  A. Evan,et al.  Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. , 1987, Transplantation.

[35]  A. Novick,et al.  DETRIMENTAL EFFECT OF CYCLOSPORINE ON INITIAL FUNCTION OF CADAVER RENAL ALLOGRAFTS FOLLOWING EXTENDED PRESERVATION Results of a randomized Prospective Study , 1986, Transplantation.

[36]  P. Jablonski,et al.  CYCLOSPORINE AND THE ISCHEMIC RAT KIDNEY , 1986, Transplantation.